In addition to these clinical studies, the authors examined animal, cell and biochemical research on the form of progestin used in DMPA -- medroxyprogesterone acetate
, or MPA.
After the WHI revealed differences between the estrogen-alone and estrogen-progestin study arms, implicating medroxyprogesterone acetate
for increased risk of breast cancer, why is Provera still being advocated by the American College of Obstetricians and Gynecologists as a progestin safe for use in menopause?
In addition, 40 underwent Bilateral Tubal Ligation (BTL), 21 opted for the implant which is the depot medroxyprogesterone acetate
(DMPA), 11 used the Intra Uterine Device (IUD), 60 chose injectable, and one underwent vasectomy.
Informed consent was taken and the patient was initiated on depot medroxyprogesterone acetate
injection 150 mg intramuscular, every fortnight.
In this study, we sought to determine whether apigenin, a low molecular weight anti-carcinogenic flavonoid, inhibits the growth of aggressive Her2/neu-positive BT-474 xenograft tumors in nude mice exposed to medroxyprogesterone acetate
(MPA), the most commonly used progestin in the USA.
5-mg medroxyprogesterone acetate
group, and one in the placebo group.
Determining the onset of menopause in older users of hormonal injectable contraceptives depot medroxyprogesterone acetate
(DMPA) and norethisterone enanthate (NET-EN) can be challenging.
The researchers collected scents before and after giving the lemurs a form of the hormone progestin called medroxyprogesterone acetate
, or MPA, sold as Depo-Provera.
TORONTO -- Bone mineral density loss in female adolescents receiving depot medroxyprogesterone acetate
for contraception was substantially or fully reversible following discontinuation of the drug, based on study results.
LAS VEGAS -- Abnormally low levels of vitamin D were seen in a subset of 15 adolescent girls who had substantial losses in bone mineral density while using depot medroxyprogesterone acetate
for contraception, according to preliminary results from a prospective study presented at the annual meeting of the North American Society for Pediatric and Adolescent Gynecology.
16,608 postmenopausal women aged 50-79 were randomly assigned to placebo (n=8,102) or a combination of conjugated equine oestrogen and medroxyprogesterone acetate
(MPA), a synthetic progestin, decreases vascular endothelium function in premenopausal women, according to an April 2008 study from the University of Oregon.